These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33852916)

  • 1. Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells.
    Wing PAC; Keeley TP; Zhuang X; Lee JY; Prange-Barczynska M; Tsukuda S; Morgan SB; Harding AC; Argles ILA; Kurlekar S; Noerenberg M; Thompson CP; Huang KA; Balfe P; Watashi K; Castello A; Hinks TSC; James W; Ratcliffe PJ; Davis I; Hodson EJ; Bishop T; McKeating JA
    Cell Rep; 2021 Apr; 35(3):109020. PubMed ID: 33852916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of alveolar epithelial ER stress by β-coronavirus infection disrupts surfactant homeostasis in mice: implications for COVID-19 respiratory failure.
    Murthy A; Rodriguez LR; Dimopoulos T; Bui S; Iyer S; Chavez K; Tomer Y; Abraham V; Cooper C; Renner DM; Katzen JB; Bentley ID; Ghadiali SN; Englert JA; Weiss SR; Beers MF
    Am J Physiol Lung Cell Mol Physiol; 2024 Aug; 327(2):L232-L249. PubMed ID: 38860845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage Activation Syndrome in Coinciding Pandemics of Obesity and COVID-19: Worse than Bad.
    Engin AB; Engin ED; Engin A
    Adv Exp Med Biol; 2024; 1460():919-954. PubMed ID: 39287877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of SARS-CoV-2 culture from clinical samples for clinical trial applications.
    Wooding D; Buist K; Romero-Ramirez A; Savage H; Watkins R; Bengey D; Greenland-Bews C; Thompson CR; Kontogianni N; Body R; Hayward G; Byrne RL; Gould S; ; Myerscough C; Atkinson B; Shaw V; Greenhalf B; Adams E; Cubas-Atienzar A; Khoo S; Fletcher T; Edwards T
    mSphere; 2024 Nov; 9(11):e0030424. PubMed ID: 39412283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo.
    Tsugawa Y; Furukawa K; Ise T; Takayama M; Ota T; Kuroda T; Shano S; Hashimoto T; Konishi H; Ishihara T; Sato M; Kamada H; Fukao K; Shishido T; Yoshikawa M; Takahashi T; Nagata S
    PLoS One; 2024; 19(12):e0300297. PubMed ID: 39621673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AI Promoted Virtual Screening, Structure-Based Hit Optimization, and Synthesis of Novel COVID-19 S-RBD Domain Inhibitors.
    Gkekas I; Katsamakas S; Mylonas S; Fotopoulou T; Magoulas GΕ; Tenchiu AC; Dimitriou M; Axenopoulos A; Rossopoulou N; Kostova S; Wanker EE; Katsila T; Papahatjis D; Gorgoulis VG; Koufaki M; Karakasiliotis I; Calogeropoulou T; Daras P; Petrakis S
    J Chem Inf Model; 2024 Nov; 64(22):8562-8585. PubMed ID: 39535926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry.
    Zhang Z; Takenaga T; Fehling SK; Igarashi M; Hirokawa T; Muramoto Y; Yamauchi K; Onishi C; Nakano M; Urata S; Groseth A; Strecker T; Noda T
    J Virol; 2024 Jul; 98(7):e0071424. PubMed ID: 38809021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of prolyl hydroxylase 1 and 2 in SM22α-expressing cells prevents Hypoxia-Induced pulmonary hypertension.
    Barnes EA; Ito R; Che X; Alvira CM; Cornfield DN
    Am J Physiol Lung Cell Mol Physiol; 2023 Dec; 325(6):L741-L755. PubMed ID: 37847687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shikonin induces ferroptosis in osteosarcomas through the mitochondrial ROS-regulated HIF-1α/HO-1 axis.
    Lu C; Zhang Z; Fan Y; Wang X; Qian J; Bian Z
    Phytomedicine; 2024 Dec; 135():156139. PubMed ID: 39423479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids.
    Kakizaki M; Hashimoto R; Nagata N; Yamamoto T; Okura T; Katoh H; Kitai Y; Akahori Y; Shirato K; Ryo A; Takayama K; Takeda M
    J Virol; 2024 Nov; ():e0185324. PubMed ID: 39601592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.
    Essink BJ; Shapiro C; Isidro MGD; Bradley P; Pragalos A; Bloch M; Santiaguel J; Frias MV; Miyakis S; Alves de Mesquita M; Berrè S; Servais C; Waugh N; Hoffmann C; Baba E; Schönborn-Kellenberger O; Wolz OO; Koch SD; Ganyani T; Boutet P; Mann P; Mueller SO; Ramanathan R; Gaudinski MR; Vanhoutte N
    Hum Vaccin Immunother; 2024 Dec; 20(1):2408863. PubMed ID: 39422261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional importance of Dicer protein in the adaptive cellular response to hypoxia.
    Ho JJ; Metcalf JL; Yan MS; Turgeon PJ; Wang JJ; Chalsev M; Petruzziello-Pellegrini TN; Tsui AK; He JZ; Dhamko H; Man HS; Robb GB; Teh BT; Ohh M; Marsden PA
    J Biol Chem; 2012 Aug; 287(34):29003-20. PubMed ID: 22745131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose Tissue Hypoxia in Obesity: Clinical Reappraisal of Hypoxia Hypothesis.
    Engin A
    Adv Exp Med Biol; 2024; 1460():329-356. PubMed ID: 39287857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitriol prevents SARS-CoV spike-induced inflammation in human trophoblasts through downregulating ACE2 and TMPRSS2 expression.
    Vargas-Castro R; García-Quiroz J; Olmos-Ortiz A; Avila E; Larrea F; Díaz L
    J Steroid Biochem Mol Biol; 2025 Jan; 245():106625. PubMed ID: 39515592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic.
    Akerman A; Fichter C; Milogiannakis V; Esneau C; Silva MR; Ison T; Lopez JA; Naing Z; Caguicla J; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Boss T; Condylios A; Yeang M; Sato K; Bartlett NN; Darley D; Matthews G; Stark DJ; Promsri S; Rawlinson WD; Murrell B; Kelleher AD; Dwyer D; Sintchenko V; Kok J; Ellis S; Marris K; Knight E; Hoad VC; Irving DO; Gosbell I; Brilot F; Wood J; Aggarwal A; Turville SG
    EBioMedicine; 2024 Dec; 110():105415. PubMed ID: 39549677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2.
    Wang J; Beyer D; Vaccarin C; He Y; Tanriver M; Benoit R; Deupi X; Mu L; Bode JW; Schibli R; Müller C
    Eur J Nucl Med Mol Imaging; 2024 Dec; 52(1):9-21. PubMed ID: 39066808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization.
    Gu M; Torres JL; Li Y; Van Ry A; Greenhouse J; Wallace S; Chiang CI; Pessaint L; Jackson AM; Porto M; Kar S; Li Y; Ward AB; Wang Y
    Emerg Microbes Infect; 2021 Dec; 10(1):2016-2029. PubMed ID: 34651563
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.